Brevetti EPO No.3953377 2025.09.17
Brevetti EPO
(10) Registration Number and Date
2026000100 2026.03.03
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000100 2020.04.10
(40) Publication Number and Date
SM /T/2026/000100 2026.03.03
(30) Priority Details
US 201962954089 P
2019.12.27
US 202062988665 P
2020.03.12
US 201962934450 P
2019.11.12
US 202062960471 P
2020.01.13
US 201962831846 P
2019.04.10
(71/73) Applicant
(IT) PREVAIL THERAPEUTICS, INC. : Lilly Corporate Center, Indianapolis, Indiana 46285, US
(72) Inventor
(IT) LIN, Hsuan-Ni : 430 East 29th Street, Suite 940, New York, New York 10016, US
(IT) HEFTI, Franz : 20 East 74th Street, Apt. 14F, New York, New York 10021, US
(IT) HECKMAN, Laura : 430 East 29th Street, Suite 940, New York, New York 10016, US
(IT) WONG, Li Chin : 430 East 29th Street, Suite 940, New York, New York 10016, US
(IT) ABELIOVICH, Asa : 20 East 35th Street, Apt. 15E, New York, New York 10016, US
(IT) RHINN, Herve : 430 East 29th Street, Suite 940, New York, New York 10016, US
(74) Representative Name
(IT) MARI, Marco Giovanni : Via Tre Settembre, 154, 47891 Dogana RSM, SM
(54) Title
(IT) TERAPIE GENICHE PER DISTURBI LISOSOMIALI
(EN) GENE THERAPIES FOR LYSOSOMAL DISORDERS
(57) Abstract
(58) Citations